Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 165715, 8 pages
http://dx.doi.org/10.1155/2013/165715
Research Article

LPS Increases MUC5AC by TACE/TGF-α/EGFR Pathway in Human Intrahepatic Biliary Epithelial Cell

1Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, No. 29 Gaotanyan Street, Shapingba District, Chongqing 400038, China
2The 306th Hospital of PLA, No. 9 Anxiang Road (N), Chaoyang District, Beijing 100101, China

Received 4 April 2013; Revised 15 July 2013; Accepted 18 July 2013

Academic Editor: Dimitrios P. Bogdanos

Copyright © 2013 Zipei Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X.-G. Chen, J.-Q. Liu, M.-H. Peng et al., “Clinical epidemiological study on intrahepatic cholelithiasis: analysis of 8585 cases,” Hepatobiliary and Pancreatic Diseases International, vol. 2, no. 2, pp. 281–284, 2003. View at Google Scholar · View at Scopus
  2. N. Jarufe, E. Figueroa, C. Munoz et al., “Anatomic hepatectomy as a definitive treatment for hepatolithiasis: a cohort study,” HPB, vol. 14, no. 9, pp. 604–610, 2012. View at Publisher · View at Google Scholar
  3. N. Ozcan, G. Kahriman, and E. Mavili, “Percutaneous transhepatic removal of bile duct stones: results of 261 patients,” CardioVascular and Interventional Radiology, vol. 35, no. 3, pp. 621–627, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. K. Cheon, Y. D. Cho, J. H. Moon, J. S. Lee, and C. S. Shim, “Evaluation of long-term results and recurrent factors after operative and nonoperative treatment for hepatolithiasis,” Surgery, vol. 146, no. 5, pp. 843–853, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Sasaki, H. Ikeda, and Y. Nakanuma, “Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: physiological distribution and pathological significance,” Progress in Histochemistry and Cytochemistry, vol. 42, no. 2, pp. 61–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. D. J. Thornton, K. Rousseau, and M. A. McGuckin, “Structure and function of the polymeric mucins in airways mucus,” Annual Review of Physiology, vol. 70, pp. 459–486, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Ham and J. D. Kaunitz, “Gastroduodenal mucosal defense,” Current Opinion in Gastroenterology, vol. 24, no. 6, pp. 665–673, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Zen, K. Harada, M. Sasaki et al., “Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasis,” American Journal of Pathology, vol. 161, no. 4, pp. 1475–1484, 2002. View at Google Scholar · View at Scopus
  9. F. Li, Y. Zhou, N. Cheng et al., “Epidermal growth factor receptor as a target for anti-proliferative treatment of proliferative cholangitis in hepatolithiasis,” Journal of Surgical Research, vol. 166, no. 1, pp. 87–94, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. C. A. Hewson, J. J. Haas, N. W. Bartlett et al., “Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-κB and EGFR pathways,” European Respiratory Journal, vol. 36, no. 6, pp. 1425–1435, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Finzi, V. Barbu, P.-R. Burgel et al., “MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptor pathway in the human gallbladder,” American Journal of Pathology, vol. 169, no. 6, pp. 2031–2041, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Perrais, P. Pigny, M.-C. Copin, J.-P. Aubert, and I. van Seuningen, “Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor/Ras/Raf/extracellular signal-regulated kinase cascade and Sp1,” Journal of Biological Chemistry, vol. 277, no. 35, pp. 32258–32267, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Rose-John, “ADAM17, shedding, TACE as therapeutic targets,” Pharmacological Research, vol. 71, pp. 19–22, 2013. View at Publisher · View at Google Scholar
  14. F. Tian, L. Cheng, D. Li et al., “Downregulation of mucins in graft bile ducts after liver transplantation in rats,” Transplantation, vol. 92, no. 5, pp. 529–535, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Ishikawa, M. Sasaki, S. Ohira et al., “Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis,” Laboratory Investigation, vol. 84, no. 5, pp. 629–638, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Enache, C. E. Simionescu, and A. Stepan, “EGFR and Her2/neu immunoexpression in papillary urothelial bladder carcinomas,” Romanian Journal of Morphology and Embryology, vol. 54, no. 1, pp. 137–141, 2013. View at Google Scholar
  17. L. Zhao, R. Yang, L. Cheng, M. Wang, Y. Jiang, and S. Wang, “LPS-induced epithelial-mesenchymal transition of intrahepatic biliary epithelial cells,” Journal of Surgical Research, vol. 171, no. 2, pp. 819–825, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Yamasaki, F. Nakayama, S. Tamura, and M. Endo, “Characterization of mucin in the hepatic bile of patients with intrahepatic pigment stones,” Journal of Gastroenterology and Hepatology, vol. 7, no. 1, pp. 36–41, 1992. View at Google Scholar · View at Scopus
  19. M. Sasaki, Y. Nakanuma, and Y. S. Kim, “Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction,” Hepatology, vol. 27, no. 1, pp. 54–61, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. C. Nie, H. Wu, P. B. Li et al., “Characteristic comparison of three rat models induced by cigarette smoke or combined with LPS: to establish a suitable model for study of airway mucus hypersecretion in chronic obstructive pulmonary disease,” Pulmonary Pharmacology & Therapeutics, vol. 25, no. 5, pp. 349–356, 2012. View at Publisher · View at Google Scholar
  21. W. Wang, X. Xu, M. Zheng, and L. Wan, “Lipopolysaccharides induces MUC5AC overproduction in human nasal epithelium,” European Archives of Oto-Rhino-Laryngology, vol. 270, no. 2, pp. 541–547, 2013. View at Publisher · View at Google Scholar
  22. M. G. Binker, A. A. Binker-Cosen, D. Richards, B. Oliver, and L. I. Cosen-Binker, “LPS-stimulated MUC5AC production involves Rac1-dependent MMP-9 secretion and activation in NCI-H292 cells,” Biochemical and Biophysical Research Communications, vol. 386, no. 1, pp. 124–129, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. U. Sahin, G. Weskamp, K. Kelly et al., “Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands,” Journal of Cell Biology, vol. 164, no. 5, pp. 769–779, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. P. A. Kenny, “TACE: a new target in epidermal growth factor receptor dependent tumors,” Differentiation, vol. 75, no. 9, pp. 800–808, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Liu, Q. Li, X. Zhou, V. P. Kolosov, and J. M. Perelman, “Rhythmic pressure waves induce Mucin5AC expression via an EGFR-mediated signaling pathway in human airway epithelial cells,” DNA and Cell Biology, vol. 32, no. 8, pp. 423–429, 2013. View at Publisher · View at Google Scholar
  26. R. R. Hodges, J. A. Bair, R. B. Carozza, D. Li, M. A. Shatos, and D. A. Dartt, “Signaling pathways used by EGF to stimulate conjunctival goblet cell secretion,” Experimental Eye Research, vol. 103, no. 1, pp. 99–113, 2012. View at Publisher · View at Google Scholar